Browse by Manufacturer Name

0-9 A B C D E F G H I J K L M N O P Q R S T U V W X Y Z

Genentech (323)

Medicines Manufacturer

Genentech is a leading biotechnology company that discovers, develops, manufactures and commercializes medicines to treat patients with serious or life-threatening medical conditions

Showing 1 to 200 of 323 entries
Datasheet PDF or ZIP
EEOistheLaw - EEO is the Law - Now Hiring EEOistheLaw : EEO is the Law (PDF)
EEOistheLaw - EEO is the - Find a job EEOistheLaw : EEO is the (PDF)
Boniva Injection Prescribing - Boniva Injection® (ibandronate sodium) - Our Medicines Boniva Injection Prescribing : Boniva Injection® (ibandronate sodium) (PDF)
Boniva Tablets Prescribing - Boniva Tablets® (ibandronate sodium) - Our Medicines Boniva Tablets Prescribing : Boniva Tablets® (ibandronate sodium) (PDF)
Copegus Prescribing - Copegus® (ribavirin) - Our Medicines Copegus Prescribing : Copegus® (ribavirin) (PDF)
Cytovene Prescribing - Cytovene® (ganciclovir) - Our Medicines Cytovene Prescribing : Cytovene® (ganciclovir) (PDF)
Invirase Prescribing - Invirase® (saquinavir mesylate) - Our Medicines Invirase Prescribing : Invirase® (saquinavir mesylate) (PDF)
Klonopin Prescribing - Klonopin® (clonazepam) - Our Medicines Klonopin Prescribing : Klonopin® (clonazepam) (PDF)
Valium Prescribing - Valium® (diazepam) - Our Medicines Valium Prescribing : Valium® (diazepam) (PDF)
Xeloda Prescribing - Xeloda® (capecitabine) - Our Medicines Xeloda Prescribing : Xeloda® (capecitabine) (PDF)
8209.full - View Article - Infectious Disease 8209.full : View Article (PDF)
ALECENSACapsules150mgSDS - ALECENSA(R) Capsules (150 mg) - Our Medicines ALECENSACapsules150mgSDS : ALECENSA(R) Capsules (150 mg) (PDF)
Avastin HCP Necrotizing - Important Drug Warning: Necrotizing Fasciitis - Apr 2013 - Our Medicines Avastin HCP Necrotizing : Important Drug Warning: Necrotizing Fasciitis - Apr 2013 (PDF)
Avastin DHCP 022012 - Warning for Counterfeit Product Labeled as Avastin in the United States Feb 2012 - Our Medicines Avastin DHCP 022012 : Warning for Counterfeit Product Labeled as Avastin in the United States Feb 2012 (PDF)
Avastin Informationforhp - Important Change to Avastin® label for treatment of metastatic breast cancer - Nov 2011 - Our Medicines Avastin Informationforhp : Important Change to Avastin® label for treatment of metastatic breast cancer - Nov 2011 (PDF)
Avastin Dear HCP Letter - Important New Safety Information in Women Receiving AVASTIN - Oct 2011 - Our Medicines Avastin Dear HCP Letter : Important New Safety Information in Women Receiving AVASTIN - Oct 2011 (PDF)
Avastin Ocular Letter 122008 - Intraocular Inflammatory Reactions - Dec 2008 - Our Medicines Avastin Ocular Letter 122008 : Intraocular Inflammatory Reactions - Dec 2008 (PDF)
Avastin Maha Letter - Microangiopathic Hemolytic Anemia (MAHA) - July 2008 - Our Medicines Avastin Maha Letter : Microangiopathic Hemolytic Anemia (MAHA) - July 2008 (PDF)
Avastin Te Letter - Tracheoesophageal (TE) Fistula - April 2007 - Our Medicines Avastin Te Letter : Tracheoesophageal (TE) Fistula - April 2007 (PDF)
Avastin DHCP Letter - Cases of RPLS in Patients Receiving AVASTIN - Sept 2006 - Our Medicines Avastin DHCP Letter : Cases of RPLS in Patients Receiving AVASTIN - Sept 2006 (PDF)
Avastin HCPLetter 08262008 - VEGF antibodies for the treatment of retinopathy of prematurity - Aug 2006 - Our Medicines Avastin HCPLetter 08262008 : VEGF antibodies for the treatment of retinopathy of prematurity - Aug 2006 (PDF)
AvastinVials100mgSDS3 - AVASTIN(R) Vials (100 mg) - Our Medicines AvastinVials100mgSDS3 : AVASTIN(R) Vials (100 mg) (PDF)
AvastinVials400mgSDS3 - AVASTIN(R) Vials (400 mg) - Our Medicines AvastinVials400mgSDS3 : AVASTIN(R) Vials (400 mg) (PDF)
CotellicTablets20mgSDS2 - COTELLIC Tablets (20 mg) - Our Medicines CotellicTablets20mgSDS2 : COTELLIC Tablets (20 mg) (PDF)
Erivedge DHCP Letter November2016 - Important Drug Warning - November 2016 - Our Medicines Erivedge DHCP Letter November2016 : Important Drug Warning - November 2016 (PDF)
Erivedge DHCP Letter June2016 - Serious Risk with Use of Erivedge (vismodegib) Capsules: Premature Epiphyseal Fusion - June 2016 - Our Medicines Erivedge DHCP Letter June2016 : Serious Risk with Use of Erivedge (vismodegib) Capsules: Premature Epiphyseal Fusion - June 2016 (PDF)
Erivedge HCP Letter February2016 - Extension of Pregnancy Prevention Duration for Women of Childbearing Potential and Waiting Periods for Blood Donations and Lactation in Patients taking ERIVEDGE (vismodegib) capsule - February 2016 - Our Medicines Erivedge HCP Letter February2016 : Extension of Pregnancy Prevention Duration for Women of Childbearing Potential and Waiting Periods for Blood Donations and Lactation in Patients taking ERIVEDGE (vismodegib) capsule - February 2016 (PDF)
ErivedgeCapsules150mgSDS3 - ERIVEDGE(R) Capsules (150 mg) - Our Medicines ErivedgeCapsules150mgSDS3 : ERIVEDGE(R) Capsules (150 mg) (PDF)
GA101 DHPL Final signed 14 Feb 2014 - Gazyva TM (obinutuzumab) Important Drug Warning: Thrombocytopenia - Feb 2014 - Our Medicines GA101 DHPL Final signed 14 Feb 2014 : Gazyva TM (obinutuzumab) Important Drug Warning: Thrombocytopenia - Feb 2014 (PDF)
GAZYVAVials1000mgper40mlMSDS (1) - 40 ml) - Our Medicines GAZYVAVials1000mgper40mlMSDS (1) : 40 ml) (PDF)
Herceptin Dhcp - 440mg Vials and Herceptin BWFI Diluent - June 2008 - Our Medicines Herceptin Dhcp : 440mg Vials and Herceptin BWFI Diluent - June 2008 (PDF)
Herceptin Ddl - Updated Cardiotoxicity Information - Aug 2005 - Our Medicines Herceptin Ddl : Updated Cardiotoxicity Information - Aug 2005 (PDF)
Herceptin Idw-dhpl - Fatal Embryo-Fetal Toxicity due to Herceptin Exposure During Pregnancy - Our Medicines Herceptin Idw-dhpl : Fatal Embryo-Fetal Toxicity due to Herceptin Exposure During Pregnancy (PDF)
HERCEPTINVials440mgSDS3 - HERCEPTIN® Vials (440 mg) - Our Medicines HERCEPTINVials440mgSDS3 : HERCEPTIN® Vials (440 mg) (PDF)
Kadcyla HCPL 112013 - Kadcyla Important Safety Warning: Hemorrhage, Nov 2013 - Our Medicines Kadcyla HCPL 112013 : Kadcyla Important Safety Warning: Hemorrhage, Nov 2013 (PDF)
Kadcyla HCPL 052013 - KADCYLA (ado-trastuzumab emtansine) error on the carton - May 2013 - Our Medicines Kadcyla HCPL 052013 : KADCYLA (ado-trastuzumab emtansine) error on the carton - May 2013 (PDF)
KADCYLALyophilizedPowderinVials100mgSDS3 - KADCYLA(R) Lyophilized Powder in Vials (100 mg) - Our Medicines KADCYLALyophilizedPowderinVials100mgSDS3 : KADCYLA(R) Lyophilized Powder in Vials (100 mg) (PDF)
KADCYLASolutionSDS6 - KADCYLA(R) Solution - Our Medicines KADCYLASolutionSDS6 : KADCYLA(R) Solution (PDF)
KADCYLALyophilizedPowderinVials160mgSDS3 - KADCYLA(R) Lyophilized Powder in Vials (160 mg) - Our Medicines KADCYLALyophilizedPowderinVials160mgSDS3 : KADCYLA(R) Lyophilized Powder in Vials (160 mg) (PDF)
Perjeta 420mg MSDS - PERJETA(R) (420 mg) - Our Medicines Perjeta 420mg MSDS : PERJETA(R) (420 mg) (PDF)
2013.11.1 RIT0002202400 Rituxan DHCP Letter Hepatitis B Virus Reactivation Direct Mail - Rituxan® (rituximab) Label: Hepatitis B Reactivation, October 2013 - Our Medicines 2013.11.1 RIT0002202400 Rituxan DHCP Letter Hepatitis B Virus Reactivation Direct Mail : Rituxan® (rituximab) Label: Hepatitis B Reactivation, October 2013 (PDF)
Rituxan DHCP Letter - Important Drug Warning: Updated Safety Information - Dec 2006 - Our Medicines Rituxan DHCP Letter : Important Drug Warning: Updated Safety Information - Dec 2006 (PDF)
Rituxan Dhcp Letter 0908 - Important Drug Warning: New Safety Information - Sept 2008 - Our Medicines Rituxan Dhcp Letter 0908 : Important Drug Warning: New Safety Information - Sept 2008 (PDF)
Rituxan Dhcp Letter 1009 - Important Drug Warning: Updated Safety Information - Oct 2009 - Our Medicines Rituxan Dhcp Letter 1009 : Important Drug Warning: Updated Safety Information - Oct 2009 (PDF)
RituxanVials100mgper10mlSDS2 - 10 ml) - Our Medicines RituxanVials100mgper10mlSDS2 : 10 ml) (PDF)
RituxanVials500mgper50mlSDS2 - 50 ml) - Our Medicines RituxanVials500mgper50mlSDS2 : 50 ml) (PDF)
Tarceva DHCP Letter October2016 - Important Prescribing Information - October 2016 - Our Medicines Tarceva DHCP Letter October2016 : Important Prescribing Information - October 2016 (PDF)
Tarceva DHCP Letter June2016 - Important Correction of Drug Information - June 2016 - Our Medicines Tarceva DHCP Letter June2016 : Important Correction of Drug Information - June 2016 (PDF)
TarcevaTablets25mgSDS2 - TARCEVA(R) Tablets (25 mg) - Our Medicines TarcevaTablets25mgSDS2 : TARCEVA(R) Tablets (25 mg) (PDF)
TarcevaTablets100mgSDS2 - TARCEVA(R) Tablets (100 mg) - Our Medicines TarcevaTablets100mgSDS2 : TARCEVA(R) Tablets (100 mg) (PDF)
TarcevaTablets150mgSDS2 - TARCEVA(R) Tablets (150 mg) - Our Medicines TarcevaTablets150mgSDS2 : TARCEVA(R) Tablets (150 mg) (PDF)
TECENTRIQ(R)Vials1200mgper20mlSDS2 - 20 ml) - Our Medicines TECENTRIQ(R)Vials1200mgper20mlSDS2 : 20 ml) (PDF)
VenclextaTablets10mg50mg100mgSDS - VENCLEXTA(R) Tablets (10, 50 and 100 mg) - Our Medicines VenclextaTablets10mg50mg100mgSDS : VENCLEXTA(R) Tablets (10, 50 and 100 mg) (PDF)
Xeloda Prescribing - Xeloda® - Our Medicines Xeloda Prescribing : Xeloda® (PDF)
Xeloda DHCPL only - Xeloda Important Drug Warning: Stevens-Johnson Syndrome (SJS) and Toxic Epidermal Necrolysis (TEN ) - Jan 2014 - Our Medicines Xeloda DHCPL only : Xeloda Important Drug Warning: Stevens-Johnson Syndrome (SJS) and Toxic Epidermal Necrolysis (TEN ) - Jan 2014 (PDF)
Xeloda DHCP Letter - Alternative Packaging Configuration for XELODA® - March 2011 - Our Medicines Xeloda DHCP Letter : Alternative Packaging Configuration for XELODA® - March 2011 (PDF)
MSDS XELODA Tab150mg - XELODA(R) Tablets (150 mg) - Our Medicines MSDS XELODA Tab150mg : XELODA(R) Tablets (150 mg) (PDF)
MSDS XELODA Tab500mg - XELODA(R) Tablets (500 mg) - Our Medicines MSDS XELODA Tab500mg : XELODA(R) Tablets (500 mg) (PDF)
Zelboraf DHCP Letter FINAL - Important Drug Warning: Risk of Malignancy Progression and DRESS Syndrome-August 2013 - Our Medicines Zelboraf DHCP Letter FINAL : Important Drug Warning: Risk of Malignancy Progression and DRESS Syndrome-August 2013 (PDF)
ZelborafFCTablets240mgSDS - ZELBORAF(R) F.C. Tablets (240 mg) - Our Medicines ZelborafFCTablets240mgSDS : ZELBORAF(R) F.C. Tablets (240 mg) (PDF)
Actemra DCHP letter Oct 2013 - IMPORTANT SAFETY INFORMATION Regarding ACTEMRA® (tocilizumab) REMS, October 2013 - Our Medicines Actemra DCHP letter Oct 2013 : IMPORTANT SAFETY INFORMATION Regarding ACTEMRA® (tocilizumab) REMS, October 2013 (PDF)
Actemra HCPL 2011 - Actemra for RA and SJIA - June 2011 - Our Medicines Actemra HCPL 2011 : Actemra for RA and SJIA - June 2011 (PDF)
Actemra HCPLetter 102012 - Actemra for RA and SJIA - Oct 2012 - Our Medicines Actemra HCPLetter 102012 : Actemra for RA and SJIA - Oct 2012 (PDF)
ACTEMRASCPrefilledSyringes180mgmlSDS3 - 0.9 ml) - Our Medicines ACTEMRASCPrefilledSyringes180mgmlSDS3 : 0.9 ml) (PDF)
ACTEMRASterileConcentrateforInjection80mgSDS2 - ACTEMRA(R) Sterile Concentrate for Injection (80 mg) - Our Medicines ACTEMRASterileConcentrateforInjection80mgSDS2 : ACTEMRA(R) Sterile Concentrate for Injection (80 mg) (PDF)
ACTEMRASterileConcentrateforInjection200mgSDS2 - ACTEMRA(R) Sterile Concentrate for Injection (200 mg) - Our Medicines ACTEMRASterileConcentrateforInjection200mgSDS2 : ACTEMRA(R) Sterile Concentrate for Injection (200 mg) (PDF)
ACTEMRASterileConcentrateforInjection400mgSDS2 - ACTEMRA(R) Sterile Concentrate for Injection (400 mg) - Our Medicines ACTEMRASterileConcentrateforInjection400mgSDS2 : ACTEMRA(R) Sterile Concentrate for Injection (400 mg) (PDF)
ESBRIETCapsules267mgSDS5 - Esbriet Capsules (267 mg) - Our Medicines ESBRIETCapsules267mgSDS5 : Esbriet Capsules (267 mg) (PDF)
Lucentis Sailor Letter - SAILOR with AMD - Jan 2007 - Our Medicines Lucentis Sailor Letter : SAILOR with AMD - Jan 2007 (PDF)
Lucentis HCPLetter 082006 - Safety Risk with Intravitreal Use of VEGF - Aug 2006 - Our Medicines Lucentis HCPLetter 082006 : Safety Risk with Intravitreal Use of VEGF - Aug 2006 (PDF)
LucentisPFS0.5mgper0.05mlSDS - 0.05 ml) - Our Medicines LucentisPFS0.5mgper0.05mlSDS : 0.05 ml) (PDF)
LucentisVials0.3mgper0.05mlSDS - 0.05 ml) - Our Medicines LucentisVials0.3mgper0.05mlSDS : 0.05 ml) (PDF)
LucentisVials0.5mgper0.05mlSDS - 0.05 ml) - Our Medicines LucentisVials0.5mgper0.05mlSDS : 0.05 ml) (PDF)
RituxanVials500mgper50mlMSDS - 50 ml) - Our Medicines RituxanVials500mgper50mlMSDS : 50 ml) (PDF)
RituxanVials100mgper10mlMSDS - 10 ml) - Our Medicines RituxanVials100mgper10mlMSDS : 10 ml) (PDF)
XOLAIRVials150mgSDS - XOLAIR(R) Vials (150 mg) - Our Medicines XOLAIRVials150mgSDS : XOLAIR(R) Vials (150 mg) (PDF)
ActivaseVials50mgSDS3 - ACTIVASE(R) Vials (50 mg) - Our Medicines ActivaseVials50mgSDS3 : ACTIVASE(R) Vials (50 mg) (PDF)
ActivaseVials100mgSDS3 - ACTIVASE(R) Vials (100 mg) - Our Medicines ActivaseVials100mgSDS3 : ACTIVASE(R) Vials (100 mg) (PDF)
Cathflo Dear Pharmacist Letter 12 19 14 - Important Drug Information: New rubber stoppers now available - Dec 2014 - Our Medicines Cathflo Dear Pharmacist Letter 12 19 14 : Important Drug Information: New rubber stoppers now available - Dec 2014 (PDF)
Cathflo HCPLetter - Important Drug Information: Filtering Instructions for Pharmacists - Mar 2013 - Our Medicines Cathflo HCPLetter : Important Drug Information: Filtering Instructions for Pharmacists - Mar 2013 (PDF)
CathfloActivaseVials2mgSDS3 - CATHFLO ACTIVASE(R) Vials (2 mg) - Our Medicines CathfloActivaseVials2mgSDS3 : CATHFLO ACTIVASE(R) Vials (2 mg) (PDF)
Nutropin Aq Patient - Counterfeit Drug Warning - Aug 2001 - Our Medicines Nutropin Aq Patient : Counterfeit Drug Warning - Aug 2001 (PDF)
Nutropin Aq DHCPLetterTriadRecall - Safety Information Regarding Alcohol Prep Pads - Jan 2011 - Our Medicines Nutropin Aq DHCPLetterTriadRecall : Safety Information Regarding Alcohol Prep Pads - Jan 2011 (PDF)
NutropinAQ 5mgMSDS - 2 ml) - Our Medicines NutropinAQ 5mgMSDS : 2 ml) (PDF)
NutropinAQ 10mgMSDS - 2 ml) - Our Medicines NutropinAQ 10mgMSDS : 2 ml) (PDF)
NutropinAQ 20mgMSDS - 2 ml) - Our Medicines NutropinAQ 20mgMSDS : 2 ml) (PDF)
Tnkase DHCPLetterTriadRecall - Recall of Triad Group Alcohol Prep Products Due to Potential Microbial Contamination - Jan 2011 - Our Medicines Tnkase DHCPLetterTriadRecall : Recall of Triad Group Alcohol Prep Products Due to Potential Microbial Contamination - Jan 2011 (PDF)
TNKaseLyophilizedPowder50mgSDS4 - TNKase(R) Lyophilized Powder (50 mg) - Our Medicines TNKaseLyophilizedPowder50mgSDS4 : TNKase(R) Lyophilized Powder (50 mg) (PDF)
IR3rFrAq1YvtwSfdexg1vx6H6IwOWTlm - Correction of labeling provided with CellCept® Intravenous and CellCept® Oral Suspension - May 2015 - Our Medicines IR3rFrAq1YvtwSfdexg1vx6H6IwOWTlm : Correction of labeling provided with CellCept® Intravenous and CellCept® Oral Suspension - May 2015 (PDF)
Cellcept LetterPMLMay2008 - Important Changes in the CellCept® Prescribing Information - June 2008 - Our Medicines Cellcept LetterPMLMay2008 : Important Changes in the CellCept® Prescribing Information - June 2008 (PDF)
Cellcept REMS DHCP Letter - Mycophenolate REMS (Risk Evaluation and Mitigation Strategy) - 2012 - Our Medicines Cellcept REMS DHCP Letter : Mycophenolate REMS (Risk Evaluation and Mitigation Strategy) - 2012 (PDF)
Cellcept Pregnancynotice - Pregnancy Notice - 2010 - Our Medicines Cellcept Pregnancynotice : Pregnancy Notice - 2010 (PDF)
Cellcept RPhMedGuideLetter - Pharmacists: Important New Dispensing Information - Jan 2009 - Our Medicines Cellcept RPhMedGuideLetter : Pharmacists: Important New Dispensing Information - Jan 2009 (PDF)
Cellcept HCPMedGuideletter - Introduction of a CellCept Medication Guide - Jan 2009 - Our Medicines Cellcept HCPMedGuideletter : Introduction of a CellCept Medication Guide - Jan 2009 (PDF)
CellceptOralSuspensionSDS2 - CELLCEPT(R) Oral Suspension - Our Medicines CellceptOralSuspensionSDS2 : CELLCEPT(R) Oral Suspension (PDF)
CellceptCapsules250mgMSDS - CELLCEPT(R) Capsules (250 mg) - Our Medicines CellceptCapsules250mgMSDS : CELLCEPT(R) Capsules (250 mg) (PDF)
CELLCEPTLyophilizedVials500mgSDS - CELLCEPT(R) Lyophilized Vials (500 mg) - Our Medicines CELLCEPTLyophilizedVials500mgSDS : CELLCEPT(R) Lyophilized Vials (500 mg) (PDF)
MSDS-CELLCEPT Powder - CELLCEPT(R) Powder for Oral Suspension - Our Medicines MSDS-CELLCEPT Powder : CELLCEPT(R) Powder for Oral Suspension (PDF)
MSDS CELLCEPT 500mg - CELLCEPT(R) Film Coated Tablets (500 mg) - Our Medicines MSDS CELLCEPT 500mg : CELLCEPT(R) Film Coated Tablets (500 mg) (PDF)
Pegasys Healthcare Provider Letter Pre Filled Syringes - Potential Supply Constraint with PEGASYS® - March 2012 - Our Medicines Pegasys Healthcare Provider Letter Pre Filled Syringes : Potential Supply Constraint with PEGASYS® - March 2012 (PDF)
Pegasys Pharmacist Letter Pre Filled Syringes - Potential Supply Constraint with PEGASYS® - March 2012 - Our Medicines Pegasys Pharmacist Letter Pre Filled Syringes : Potential Supply Constraint with PEGASYS® - March 2012 (PDF)
Pegasys Copegus DrLetter 01 08 - Updates Package Inserts - Jan 2008 - Our Medicines Pegasys Copegus DrLetter 01 08 : Updates Package Inserts - Jan 2008 (PDF)
Pegasys Needle-Change-01-05-09 - New Med Guide for Pre-Filled Syringes - Jan 2009 - Our Medicines Pegasys Needle-Change-01-05-09 : New Med Guide for Pre-Filled Syringes - Jan 2009 (PDF)
Pegasys VialsPackagingChange-01-16-2009 - Vials Packaging Change - Jan 2009 - Our Medicines Pegasys VialsPackagingChange-01-16-2009 : Vials Packaging Change - Jan 2009 (PDF)
Pegasys New Package 8-9-06 - Vials Packaging Change - Aug 2006 - Our Medicines Pegasys New Package 8-9-06 : Vials Packaging Change - Aug 2006 (PDF)
XJ1wPxyL0Lbwg8NGe77XBCCFvczSIYiZ - Ml) - Our Medicines XJ1wPxyL0Lbwg8NGe77XBCCFvczSIYiZ : Ml) (PDF)
KaWNWz9LLhGIY04aiSp7jgDgBSwTaTnA - 0.5 ml) - Our Medicines KaWNWz9LLhGIY04aiSp7jgDgBSwTaTnA : 0.5 ml) (PDF)
ULRpbeFKC90VFybO0fCcLjqYzxGUMSYQ - 0.5 ml) - Our Medicines ULRpbeFKC90VFybO0fCcLjqYzxGUMSYQ : 0.5 ml) (PDF)
R5fOcbg2uUa0B5CowO7K1v4qrAJwXBV2 - 0.5 ml) - Our Medicines R5fOcbg2uUa0B5CowO7K1v4qrAJwXBV2 : 0.5 ml) (PDF)
Pulmozyme MSDS - Pulmozyme(R) Inhalation Solution (2.5 mg) - Our Medicines Pulmozyme MSDS : Pulmozyme(R) Inhalation Solution (2.5 mg) (PDF)
2013.8.12 Tamiflu Dear Pharmacist Letter Removal of Dosing Dispenser - Tamiflu Dear Pharmacist Letter Removal of Dosing Dispenser-Aug 2013 - Our Medicines 2013.8.12 Tamiflu Dear Pharmacist Letter Removal of Dosing Dispenser : Tamiflu Dear Pharmacist Letter Removal of Dosing Dispenser-Aug 2013 (PDF)
Tamiflu HCP Under One - Important Prescribing Information for Patients Under 1 - Jan 2013 - Our Medicines Tamiflu HCP Under One : Important Prescribing Information for Patients Under 1 - Jan 2013 (PDF)
TAMIFLU(R)Capsules30mgSDS4 - TAMIFLU(R) Capsules (30 mg) - Our Medicines TAMIFLU(R)Capsules30mgSDS4 : TAMIFLU(R) Capsules (30 mg) (PDF)
TAMIFLU(R)Capsules45mgSDS4 - TAMIFLU(R) Capsules (45 mg) - Our Medicines TAMIFLU(R)Capsules45mgSDS4 : TAMIFLU(R) Capsules (45 mg) (PDF)
TAMIFLU(R)Capsules75mgSDS5 - TAMIFLU(R) Capsules (75 mg) - Our Medicines TAMIFLU(R)Capsules75mgSDS5 : TAMIFLU(R) Capsules (75 mg) (PDF)
TamifluOralSuspension2 - TAMIFLU(R) Oral Suspension - Our Medicines TamifluOralSuspension2 : TAMIFLU(R) Oral Suspension (PDF)
MSDS-TAMIFLU Powder - TAMIFLU(R) Powder for Oral Suspension - Our Medicines MSDS-TAMIFLU Powder : TAMIFLU(R) Powder for Oral Suspension (PDF)
6fOslOa4iivXvuJL1oYYiTlSneyRRxub - Important Changes to Prescribing Information for Pediatric Patients: Dosing and Administration, Adverse Reactions - June 2015 - Our Medicines 6fOslOa4iivXvuJL1oYYiTlSneyRRxub : Important Changes to Prescribing Information for Pediatric Patients: Dosing and Administration, Adverse Reactions - June 2015 (PDF)
Valcyte HCPLetter 091310 - Pediatric Dosing of Valcyte - Our Medicines Valcyte HCPLetter 091310 : Pediatric Dosing of Valcyte (PDF)
VALCYTEPowderforOralSolution50mgpermlSDS2 - Ml) - Our Medicines VALCYTEPowderforOralSolution50mgpermlSDS2 : Ml) (PDF)
VALCYTEFCTablets450mgSDS - VALCYTE(R) F.C. Tablets (450 mg) - Our Medicines VALCYTEFCTablets450mgSDS : VALCYTE(R) F.C. Tablets (450 mg) (PDF)
Boniva Injection Prescribing - Boniva Injection® - Our Medicines Boniva Injection Prescribing : Boniva Injection® (PDF)
Boniva Injection HCPLetter 102012 - Safety Information Concerning Infusion Set - Oct 2012 - Our Medicines Boniva Injection HCPLetter 102012 : Safety Information Concerning Infusion Set - Oct 2012 (PDF)
13 PDRAlert Boniva HR052413 - BONIVA (ibandronate sodium) Injection Warning and Precaution Regarding Anaphylaxis Including Fatal Events - June 2013 - Our Medicines 13 PDRAlert Boniva HR052413 : BONIVA (ibandronate sodium) Injection Warning and Precaution Regarding Anaphylaxis Including Fatal Events - June 2013 (PDF)
Boniva Injection HCPLetter 08222011 - New NDC for 3mg Injection - Aug 2011 - Our Medicines Boniva Injection HCPLetter 08222011 : New NDC for 3mg Injection - Aug 2011 (PDF)
6l7xkY3NpOX7MkNYw8Y94yt38QGJw6zD - 3 ml pre-filled syringes) - Our Medicines 6l7xkY3NpOX7MkNYw8Y94yt38QGJw6zD : 3 ml pre-filled syringes) (PDF)
Boniva Tablets Prescribing - Boniva Tablets® - Our Medicines Boniva Tablets Prescribing : Boniva Tablets® (PDF)
MSDS BonivaTablets150mg - BONIVA(R) F. C. Tablets (150 mg) - Our Medicines MSDS BonivaTablets150mg : BONIVA(R) F. C. Tablets (150 mg) (PDF)
Copegus Prescribing - Copegus® - Our Medicines Copegus Prescribing : Copegus® (PDF)
COPEGUSFCTablets200mgSDS3 - Copegus F.C. Tablets (200 mg) - Our Medicines COPEGUSFCTablets200mgSDS3 : Copegus F.C. Tablets (200 mg) (PDF)
Cytovene Prescribing - Cytovene® - Our Medicines Cytovene Prescribing : Cytovene® (PDF)
CYTOVENEIV500mgpervial - Vial) - Our Medicines CYTOVENEIV500mgpervial : Vial) (PDF)
Fuzeon 043008 - Shipping Label Change - April 2008 - Our Medicines Fuzeon 043008 : Shipping Label Change - April 2008 (PDF)
Fuzeon HCPLetter 81611 - Supplier Change for Sterile Water Vials - Aug 2011 - Our Medicines Fuzeon HCPLetter 81611 : Supplier Change for Sterile Water Vials - Aug 2011 (PDF)
FUZEONLyophilizedVials90mgSDS2 - FUZEON(R) Lyophilized Vials (90 mg) - Our Medicines FUZEONLyophilizedVials90mgSDS2 : FUZEON(R) Lyophilized Vials (90 mg) (PDF)
Invirase Prescribing - Invirase® - Our Medicines Invirase Prescribing : Invirase® (PDF)
Invirase HCPletter 022813 - Pediatric Use and Potential for QT and PR Interval Prolongation - Feb 2013 - Our Medicines Invirase HCPletter 022813 : Pediatric Use and Potential for QT and PR Interval Prolongation - Feb 2013 (PDF)
Invirase HCPLetter 112010 - QT and PR Potential Drug Interactions - Nov 2010 - Our Medicines Invirase HCPLetter 112010 : QT and PR Potential Drug Interactions - Nov 2010 (PDF)
Invirase DearDoctorLetter - Update to Package Insert - Feb 2008 - Our Medicines Invirase DearDoctorLetter : Update to Package Insert - Feb 2008 (PDF)
Invirase HCPLetter 052005 - Discontinue Soft-Gel Formulation of Saquinavir - May 2005 - Our Medicines Invirase HCPLetter 052005 : Discontinue Soft-Gel Formulation of Saquinavir - May 2005 (PDF)
MSDS INVIRASE CapMix200mg - INVIRASE(R) Capsules (200 mg) - Our Medicines MSDS INVIRASE CapMix200mg : INVIRASE(R) Capsules (200 mg) (PDF)
MSDS INVIRASE CapMix500mg - INVIRASE(R) F.C. Tablets (500 mg) - Our Medicines MSDS INVIRASE CapMix500mg : INVIRASE(R) F.C. Tablets (500 mg) (PDF)
Klonopin Prescribing - Klonopin® - Our Medicines Klonopin Prescribing : Klonopin® (PDF)
Klonopin DHCP Letter January2017 - Important Drug Warning - January 2017 - Our Medicines Klonopin DHCP Letter January2017 : Important Drug Warning - January 2017 (PDF)
Klonopin BackOrder 3172009 - Supply Shortage of Wafers - March 2009 - Our Medicines Klonopin BackOrder 3172009 : Supply Shortage of Wafers - March 2009 (PDF)
Klonopin SupplyShortage 02108 - Supply Shortage of Wafers - Feb 2008 - Our Medicines Klonopin SupplyShortage 02108 : Supply Shortage of Wafers - Feb 2008 (PDF)
Klonopin WafersShortDating 113007 - Short Dated Supply - Nov 2007 - Our Medicines Klonopin WafersShortDating 113007 : Short Dated Supply - Nov 2007 (PDF)
YAoITj1Gf8e9thl15OUqUDMzUXhDo3cG - KLONOPIN(R) Tablets (0.5 mg) - Our Medicines YAoITj1Gf8e9thl15OUqUDMzUXhDo3cG : KLONOPIN(R) Tablets (0.5 mg) (PDF)
LocnG9e7PeAaHDjWrPTHG7nBxNUOa7gZ - KLONOPIN(R) Tablets (1.0 mg) - Our Medicines LocnG9e7PeAaHDjWrPTHG7nBxNUOa7gZ : KLONOPIN(R) Tablets (1.0 mg) (PDF)
67gFzgdVZUm16wKuUSvDL8sBnrpDjre0 - KLONOPIN(R) Tablets (2.0 mg) - Our Medicines 67gFzgdVZUm16wKuUSvDL8sBnrpDjre0 : KLONOPIN(R) Tablets (2.0 mg) (PDF)
Valium Prescribing - Valium® - Our Medicines Valium Prescribing : Valium® (PDF)
Valium-Klonopin DHCP Letter January2017 - Important Drug Warning - January 2017 - Our Medicines Valium-Klonopin DHCP Letter January2017 : Important Drug Warning - January 2017 (PDF)
VALIUM(R) Tablets (2 mg) - VALIUM(R) Tablets (2 mg) - Our Medicines VALIUM(R) Tablets (2 mg) : VALIUM(R) Tablets (2 mg) (PDF)
VALIUM(R) Tablets (5 mg) - VALIUM(R) Tablets (5 mg) - Our Medicines VALIUM(R) Tablets (5 mg) : VALIUM(R) Tablets (5 mg) (PDF)
VALIUM(R) Tablets (10 mg) - VALIUM(R) Tablets (10 mg) - Our Medicines VALIUM(R) Tablets (10 mg) : VALIUM(R) Tablets (10 mg) (PDF)
Xenical PPI - Important Patient information - Our Medicines Xenical PPI : Important Patient information (PDF)
Xenical Letter - Contraindication in Pregnancy - May 2012 - Our Medicines Xenical Letter : Contraindication in Pregnancy - May 2012 (PDF)
Xenical Important Changes - Severe Liver Injury - Sept 2010 - Our Medicines Xenical Important Changes : Severe Liver Injury - Sept 2010 (PDF)
Xenical HCPLetter 0811 - Capsule Color Change - Aug 2011 - Our Medicines Xenical HCPLetter 0811 : Capsule Color Change - Aug 2011 (PDF)
XenicalCapsules120mgSDS6 - XENICAL(R) Capsules (120 mg) - Our Medicines XenicalCapsules120mgSDS6 : XENICAL(R) Capsules (120 mg) (PDF)
Avastin PsOC MediaKit 12-06-16 - Download Media Kit - News Features Avastin PsOC MediaKit 12-06-16 : Download Media Kit (ZIP)
Tecentriq NSCLC Mediakit 10-18-16 V1 - Download Media Kit - News Features Tecentriq NSCLC Mediakit 10-18-16 V1 : Download Media Kit (ZIP)
Tecentriq NSCLC Approval B-roll.mp4 - Download B-Roll - News Features Tecentriq NSCLC Approval B-roll.mp4 : Download B-Roll (ZIP)
Flu MediaKit 2016 - Download Media Kit - News Features Flu MediaKit 2016 : Download Media Kit (ZIP)
Tamilflu Newsfeature OS Seasonal BRoll November-2016.mp4 - Download B-Roll - News Features Tamilflu Newsfeature OS Seasonal BRoll November-2016.mp4 : Download B-Roll (ZIP)
Tecentriq Newsfeature Mediakit 05-18-16 - Download Media Kit - News Features Tecentriq Newsfeature Mediakit 05-18-16 : Download Media Kit (ZIP)
Tecentriq Newsfeature Broll 05-19-16 - Download B-Roll - News Features Tecentriq Newsfeature Broll 05-19-16 : Download B-Roll (ZIP)
Venclexta Newsfeature Mediakit 04-11-16 - Download Media Kit - News Features Venclexta Newsfeature Mediakit 04-11-16 : Download Media Kit (ZIP)
Gazyva NHL Newsfeature MediaKit 03-10-16 - Download Media Kit - News Features Gazyva NHL Newsfeature MediaKit 03-10-16 : Download Media Kit (ZIP)
Alecensa NSCLC Mediakit 03-08-17 - Download Media Kit - News Features Alecensa NSCLC Mediakit 03-08-17 : Download Media Kit (ZIP)
Cobi Zelboraf B-Roll MOA HighRes October-2016.mp4 - Download B-Roll - News Features Cobi Zelboraf B-Roll MOA HighRes October-2016.mp4 : Download B-Roll (ZIP)
Cotellic Product Images October-2016 - Download Product Images - News Features Cotellic Product Images October-2016 : Download Product Images (ZIP)
Cotellic Zelboraf MOA-October-2016.pdf - Download MOA Images - News Features Cotellic Zelboraf MOA-October-2016.pdf : Download MOA Images (ZIP)
Lucentis DR Broll 02-10-15.mp4 - Download B-Roll - News Features Lucentis DR Broll 02-10-15.mp4 : Download B-Roll (ZIP)
Avastin Ovarian MediaKit 11-14-14 - Download Media Kit - News Features Avastin Ovarian MediaKit 11-14-14 : Download Media Kit (ZIP)
Avastin Ovarian Broll 11-14-14 - Download B-Roll - News Features Avastin Ovarian Broll 11-14-14 : Download B-Roll (ZIP)
Avastin Cervical MediaKit 08-14-2014 V2 - Download Media Kit - News Features Avastin Cervical MediaKit 08-14-2014 V2 : Download Media Kit (ZIP)
Avastin Cervical Broll 08-14-2014.mov - Download B-Roll - News Features Avastin Cervical Broll 08-14-2014.mov : Download B-Roll (ZIP)
Xolair Mediakit - Download Media Kit - News Features Xolair Mediakit : Download Media Kit (ZIP)
Gazyva CLL Mediakit 03-26-2015 - Download Media Kit - News Features Gazyva CLL Mediakit 03-26-2015 : Download Media Kit (ZIP)
Tarceva Mediakit - Download Media Kit - News Features Tarceva Mediakit : Download Media Kit (ZIP)
Avastin Mediakit - Download Media Kit - News Features Avastin Mediakit : Download Media Kit (ZIP)
Avastin Broll - Download B-Roll - News Features Avastin Broll : Download B-Roll (ZIP)
Actemra Media - Download Media Kit - News Features Actemra Media : Download Media Kit (ZIP)
100MM All Mediakit - Download Media Kit - News Features 100MM All Mediakit : Download Media Kit (ZIP)
100MM Broll - Download B-Roll - News Features 100MM Broll : Download B-Roll (ZIP)
100MM GenenBus - Download Images - News Features 100MM GenenBus : Download Images (ZIP)
Lucentis Media - Download Media Kit - News Features Lucentis Media : Download Media Kit (ZIP)
Lucentis Broll - Download Lucentis B-Roll - News Features Lucentis Broll : Download Lucentis B-Roll (ZIP)
Perjeta Media - Download Logo and Product Packaging - News Features Perjeta Media : Download Logo and Product Packaging (ZIP)
Perjeta Moa Images - Download Perjeta Mechanism of Action (MOA) - News Features Perjeta Moa Images : Download Perjeta Mechanism of Action (MOA) (ZIP)
Erivedge Media - Download Media Kit - News Features Erivedge Media : Download Media Kit (ZIP)
Erivedge Moa - Download Erivedge Mechanism of Action (MOA) - News Features Erivedge Moa : Download Erivedge Mechanism of Action (MOA) (ZIP)
Bcc - Download BCC Images - News Features Bcc : Download BCC Images (ZIP)
Zelboraf Media - Download Zelboraf Logo, Pills, and Packaging - News Features Zelboraf Media : Download Zelboraf Logo, Pills, and Packaging (ZIP)
Zelboraf Moa - Download Zelboraf Mechanism of Action (MOA) - News Features Zelboraf Moa : Download Zelboraf Mechanism of Action (MOA) (ZIP)
Stomach Cancer Broll - Download Stomach Cancer B-Roll - News Features Stomach Cancer Broll : Download Stomach Cancer B-Roll (ZIP)
Herceptin Media - Download Images (Media Kit) - News Features Herceptin Media : Download Images (Media Kit) (ZIP)
Napoleone-ferrara-named-2010-lasker-award-winner PressRelease - Download Press Release - News Features Napoleone-ferrara-named-2010-lasker-award-winner PressRelease : Download Press Release (PDF)
IME Genentech Tip Sheet Full June 2016 - IME Funding Request Tip Sheet - Support for Independent Medical Education We support grants for independent medical education to further the advance of medicine and healthcare. IME Genentech Tip Sheet Full June 2016 : IME Funding Request Tip Sheet (PDF)

No Results Found

Previous 1 2 Next
Supplyframe Tracking Pixel